AMPA receptor modulator-1

CAS No. 2036074-41-4

AMPA receptor modulator-1( —— )

Catalog No. M32776 CAS No. 2036074-41-4

AMPA receptor modulator-1 can be activated by glutamate, thereby modulating ion channels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 255 Get Quote
10MG 374 Get Quote
25MG 545 Get Quote
50MG 762 Get Quote
100MG 1017 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AMPA receptor modulator-1
  • Note
    Research use only, not for human use.
  • Brief Description
    AMPA receptor modulator-1 can be activated by glutamate, thereby modulating ion channels.
  • Description
    AMPA receptor modulator-1 is a potent, orally active and selective AMPAR regulatory protein TARP γ-8 negative modulator with a pIC50 of 9.7, more selective over GluA1/γ-2 (pIC50=5).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2036074-41-4
  • Formula Weight
    341.71
  • Molecular Formula
    C16H11ClF3NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C(F)(F)F)C1=C(C=2C=C3C(=C(C)C2)NC(=O)C3)C(Cl)=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ravula S, et al. Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8. ACS Med Chem Lett. 2018 Jul 13;9(8):821-826.?
molnova catalog
related products
  • AMPA receptor antago...

    AMPA receptor antagonist-2 is an AMPA receptor antagonist.

  • SYM 2081

    SYM 2081 is a specific kainate receptor agonist with an IC50 value of 35 nM for [3H]-kainate binding. SYM 2081 depolarizes the muscle and reduces the EPSP amplitude.

  • Dasolampanel

    Dasolampanel (NGX426) is an orally bioavailable, competitive antagonist of the AMPA-kainate receptors for the treatment of chronic pain conditions including neuropathic pain and migraine.